Behçet's disease diagnostic study of choice: Difference between revisions
Hamid Qazi (talk | contribs) |
Hamid Qazi (talk | contribs) |
||
| Line 36: | Line 36: | ||
#Practical clinical diagnosis (generally agreed pattern but not as strict) | #Practical clinical diagnosis (generally agreed pattern but not as strict) | ||
#'Suspected' or 'Possible' diagnosis (incomplete pattern of symptoms) | #'Suspected' or 'Possible' diagnosis (incomplete pattern of symptoms) | ||
4.International Criteria for Behçet's disease (ICBD) | |||
===International Study Group diagnostic guidelines=== | ===International Study Group diagnostic guidelines=== | ||
Revision as of 13:58, 23 April 2018
|
Behçet's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Behçet's disease diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Behçet's disease diagnostic study of choice |
|
Risk calculators and risk factors for Behçet's disease diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Currently, there is not a specific test to confirm the diagnosis of Behçet's disease. It is diagnosed clinically by specific patterns of symptoms and repeated outbreaks obtained by a thorough history of the patient's symptoms (outlined below). Behcet's disease is a diagnosis of exclusion, and other chronic inflammatory diseases should be evaluated for. The various inflammatory symptoms do not necessarily occur together, and they will vary in severity.
Diagnostic Study of Choice
Study of choice
- The pathergy test should be performed when:[1]
- The patient presented with symptoms of vision problems, mouth sores, and genital ulcers
- A positive [test] is detected in the patient.
- Behcet disease is mainly diagnosed based on clinical presentation.
Diagnostic Criteria
There are no pathognomonic laboratory tests in Behçet syndrome; as a result, the diagnosis is made on the basis of the clinical findings. In the absence of other systemic diseases, we diagnose Behçet syndrome in patients with recurrent oral aphthae (at least three times in one year) plus two of the following clinical features:
●Recurrent genital aphthae (aphthous ulceration or scarring).
●Eye lesions (including anterior or posterior uveitis, cells in vitreous on slit lamp examination, or retinal vasculitis observed by an ophthalmologist).
●Skin lesions (including erythema nodosum, pseudo-vasculitis, papulopustular lesions, or acneiform nodules consistent with Behçet syndrome).
●A positive pathergy test. Pathergy is defined by a papule 2 mm or more in size developing 24 to 48 hours after oblique insertion of a 20-gauge needle 5 mm into the skin, generally performed on the forearm.
This approach is consistent with the International Study Group (ISG) diagnostic criteria published in 1990 (table 2) [25]. These remain the most widely used and well-accepted criteria among experts in Behçet syndrome. (See 'Classification criteria' below.)
Pathergy is less common in Northern European and North American patients. Thus, it has been suggested that other features might be substituted for pathergy in these populations, including aseptic meningoencephalitis, cerebral vasculitis, recurrent phlebitis, arteritis, synovitis, or focal bowel ulceration [106].
There are patients who do not meet these criteria in whom the diagnosis of Behçet syndrome is still made, and establishing the diagnosis in such patients is much more difficult. Thus, it is often appropriate to refer a patient in whom the diagnosis of Behçet syndrome is suspected to a rheumatologist with experience in this disease.
Diagnostic Criteria
There are three levels of certainty for diagnosis:
- International Study Group diagnostic guidelines (very strict for research purposes)
- Practical clinical diagnosis (generally agreed pattern but not as strict)
- 'Suspected' or 'Possible' diagnosis (incomplete pattern of symptoms)
4.International Criteria for Behçet's disease (ICBD)
International Study Group diagnostic guidelines
The ISGD guidelines recommend the following:[2][3]
- Must have oral (aphthous) ulcers (any shape, size or number at least 3 times in any 12 months), along with 2 out of the next 4 "hallmark" symptoms:
- genital ulcers (including anal ulcers and spots in the genital region and swollen testicles or epididymitis in men),
- skin lesions (papulo-pustules, folliculitis, erythema nodosum, acne in post-adolescents not on corticosteroids),
- eye inflammation (iritis, uveitis, retinal vasculitis, cells in the vitreous),
- pathergy reaction (papule >2 mm dia. 24-48 hrs or more after needle-prick).
Practical clinical diagnosis
The practical clinical diagnosis for Behcet disease recommend the following:[1]
- mouth ulcers, along with 1 of the 4 hallmark symptoms above and with 2 of the symptoms below:
- arthritis/arthralgia,
- nervous system symptoms,
- stomach and/or bowel inflammation,
- deep vein thrombosis,
- superficial thrombophlebitis,
- cardio-vascular problems of inflammatory origin,
- inflammatory problems in chest and lungs,
- problems with hearing and/or balance,
- extreme exhaustion,
- changes of personality, psychoses,
- any other members of the family with a diagnosis of Behcet disease.
'Suspected' or 'Possible' diagnosis
Usually assigned when someone does not have mouth ulcers, or has mouth ulcers but does not have 1 of the 4 hallmark symptoms but has other symptoms and signs of inflammation, and other causes for these have been ruled out.
International Criteria for Behçet's disease (ICBD)
The International Criteria for Behçet's disease (ICBD) were developed in 2006 in an effort to improve sensitivity compared with the ISG criteria, but they are not widely accepted [111]. Each of several findings is assigned a point value; the criteria require a total of at least three points for diagnosis of Behçet syndrome:
●Genital aphthosis – Two points
●Ocular lesions (anterior uveitis, posterior uveitis, or retinal vasculitis) – Two points
●Oral aphthosis – One point
●Skin lesions (pseudofolliculitis or erythema nodosum) – One point
●Vascular lesions (superficial phlebitis, deep vein thrombosis, large vein thrombosis, arterial thrombosis, or aneurysm) – One point
●Pathergy – One point
Validation studies have estimated a sensitivity of 87 to 96.5 percent, a specificity of 88.9 to 97.3 percent, and an accuracy of 74.2 to 85.5 percent for these criteria [112].
References
- ↑ 1.0 1.1 Ferraz MB, Walter SD, Heymann R, Atra E (1995). "Sensitivity and specificity of different diagnostic criteria for Behçet's disease according to the latent class approach". Br J Rheumatol. 34 (10): 932–5. PMID 7582698.
- ↑ "Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease". Lancet. 335 (8697): 1078–80. 1990. PMID 1970380.
- ↑ Smith EL, Shmerling RH (1999). "The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement". Lupus. 8 (8): 586–95. doi:10.1191/096120399680411317. PMID 10568894.